Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Hungary

Richter To Partner Barr For Yasmin

March 2008 | Industry News

US drugmaker Barr Laboratories has announced that Hungary's leading drugmaker Gedeon Richter will collaborate with it in the production of Germany-based Bayer-Schering's oral contraceptive Yasmin (ethinylestradiol/drospirenone).

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles
10-Year Forecast Shows Limited Attraction

Industry / Hungary Hungary's pharmaceutical market grew at a rate of 6.7% in 2008, reaching a value of HUF613.9bn (US$3.57bn). While this represents a positive upward trend, government austerity measures in 2007 led to...
October 2009
Richter Seeks Partnership In 2010

Industry / Hungary Hungarian drugmaker Gedeon Richter aims to find a strategic partner during 2010, in order to market or develop medicines as the company adds products to its portfolio. CEO Erik Bogsch told Bloomberg...
October 2009
President Vetoes Health Reforms

Industry / Hungary The controversy surrounding Hungary's health reforms, which seemed to have settled down when parliament finally passed legislation on the reforms in December 2007, has come back to life after President...
January 2008
Parliament Passes Health Reform Bill

Industry / Hungary Hungary's parliament has passed its controversial health reform bill, which will allow private business into the health insurance market for the first time. Protests from tens of thousands of workers,...
December 2007
Liberalisation Impacting Pharmacies

Industry / Hungary BMI expects Hungary's OTC market to reach a value of US$0.8bn driven by growing health awareness in the county, increased consumer spending and, more recently, the liberalisation of the pharmacy sector....
December 2007
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2012 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS